195 related articles for article (PubMed ID: 26710799)
1. Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations.
Maciejewski-Duval A; Meuris F; Bignon A; Aknin ML; Balabanian K; Faivre L; Pasquet M; Barlogis V; Fieschi C; Bellanné-Chantelot C; Donadieu J; Schlecht-Louf G; Marin-Esteban V; Bachelerie F
J Leukoc Biol; 2016 Jun; 99(6):1065-76. PubMed ID: 26710799
[TBL] [Abstract][Full Text] [Related]
2. The evolution of cellular deficiency in GATA2 mutation.
Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
[TBL] [Abstract][Full Text] [Related]
3. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.
Mace EM; Hsu AP; Monaco-Shawver L; Makedonas G; Rosen JB; Dropulic L; Cohen JI; Frenkel EP; Bagwell JC; Sullivan JL; Biron CA; Spalding C; Zerbe CS; Uzel G; Holland SM; Orange JS
Blood; 2013 Apr; 121(14):2669-77. PubMed ID: 23365458
[TBL] [Abstract][Full Text] [Related]
4. Multiple Opportunistic Infections in a Woman with GATA2 Mutation.
Vila A; Dapás JI; Rivero CV; Bocanegra F; Furnari RF; Hsu AP; Holland SM
Int J Infect Dis; 2017 Jan; 54():89-91. PubMed ID: 27894982
[TBL] [Abstract][Full Text] [Related]
5. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
[TBL] [Abstract][Full Text] [Related]
6. Altered natural killer cell subset homeostasis and defective chemotactic responses in paroxysmal nocturnal hemoglobinuria.
El-Sherbiny YM; Kelly RJ; Hill A; Doody GM; Hillmen P; Cook GP
Blood; 2013 Sep; 122(11):1887-90. PubMed ID: 23881915
[TBL] [Abstract][Full Text] [Related]
7. [GATA2 deficiency].
Nonoyama S
Nihon Rinsho; 2014 Oct; 72(10):1861-9. PubMed ID: 25509816
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Altered NK Cell Compartment and Reduced CXCR4 Chemotactic Response of B Lymphocytes in an Immunodeficient Patient With HPV-Related Disease.
Doria M; Moscato GMF; Di Cesare S; Di Matteo G; Sgrulletti M; Bachelerie F; Marin-Esteban V; Moschese V
Front Immunol; 2022; 13():799564. PubMed ID: 35154113
[TBL] [Abstract][Full Text] [Related]
9. Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice.
Balabanian K; Brotin E; Biajoux V; Bouchet-Delbos L; Lainey E; Fenneteau O; Bonnet D; Fiette L; Emilie D; Bachelerie F
Blood; 2012 Jun; 119(24):5722-30. PubMed ID: 22438253
[TBL] [Abstract][Full Text] [Related]
10. GATA2 deficiency and related myeloid neoplasms.
Wlodarski MW; Collin M; Horwitz MS
Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
[TBL] [Abstract][Full Text] [Related]
11. Adaptive NK cells can persist in patients with
Schlums H; Jung M; Han H; Theorell J; Bigley V; Chiang SC; Allan DS; Davidson-Moncada JK; Dickinson RE; Holmes TD; Hsu AP; Townsley D; Winkler T; Wang W; Aukrust P; Nordøy I; Calvo KR; Holland SM; Collin M; Dunbar CE; Bryceson YT
Blood; 2017 Apr; 129(14):1927-1939. PubMed ID: 28209719
[TBL] [Abstract][Full Text] [Related]
12. Skin manifestations among GATA2-deficient patients.
Polat A; Dinulescu M; Fraitag S; Nimubona S; Toutain F; Jouneau S; Poullot E; Droitcourt C; Dupuy A
Br J Dermatol; 2018 Mar; 178(3):781-785. PubMed ID: 28440875
[TBL] [Abstract][Full Text] [Related]
13. Increased natural killer cell chemotaxis to CXCL12 in patients with multiple sclerosis.
Serrano-Pertierra E; Blanco-Gelaz MA; Oliva-Nacarino P; Martínez-Camblor P; Villafani J; López-Larrea C; Cernuda-Morollón E
J Neuroimmunol; 2015 May; 282():39-44. PubMed ID: 25903727
[TBL] [Abstract][Full Text] [Related]
14. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
[TBL] [Abstract][Full Text] [Related]
15. Generalized verrucosis in a patient with GATA2 deficiency.
West ES; Kingsbery MY; Mintz EM; Hsu AP; Holland SM; Rady PL; Tyring SK; Grossman ME
Br J Dermatol; 2014 May; 170(5):1182-6. PubMed ID: 24359037
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.
Biajoux V; Bignon A; Freitas C; Martinez V; Thelen M; Lima G; Jakez-Ocampo J; Emilie D; Llorente L; Balabanian K
J Transl Med; 2012 Dec; 10():251. PubMed ID: 23244336
[TBL] [Abstract][Full Text] [Related]
17. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
[TBL] [Abstract][Full Text] [Related]
18. [GATA2 gene mutations: 3 cases].
Perrard N; Pokeerbux MR; Quesnel B; Duployez N; Fenwarth L; Preudhomme C; Lefèvre G; Baillet C; Launay D; Terriou L
Rev Med Interne; 2022 Nov; 43(11):677-682. PubMed ID: 36041908
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
